ADCOCK INGRAM LIMITED. — Paracetamol Importer Profile

Adcock Ingram is a leading South African pharmaceutical manufacturer and distributor, headquartered in Midrand, South Africa. Established in 1890, the company has grown to become the second-largest manufacturer in the private pharmaceutical market and a significant supplier to the public sector. Adcock Ingram operates across various divisions, including Consumer, Over-the-Counter (OTC), Prescription, and Hospital products, offering a diverse range of healthcare solutions. The company is a subsidiary of The Bidvest Group Limited, a prominent South African services, trading, and distribution company. (investing.com)

With a revenue of R9.6 billion in 2024, Adcock Ingram's operations extend beyond South Africa into selected emerging markets. The company's therapeutic focus spans multiple areas, including cardiovascular health, psychiatric and neurological diseases, dermatology, and women's health. Notably, Adcock Ingram has established a presence in India through its subsidiary, Adcock Ingram Pharma Private Limited, based in Bengaluru, Karnataka. This subsidiary, incorporated in 2021, engages in drug formulation and development, highlighting the company's strategic partnerships and expansion into the Indian pharmaceutical sector. (thecompanycheck.com)

###

In South Africa, the importation of pharmaceuticals is regulated by the South African Health Products Regulatory Authority (SAHPRA). Importers must obtain the appropriate licenses, which are categorized based on the type of product and its intended use. These licenses ensure that imported pharmaceuticals meet the country's safety, efficacy, and quality standards. Labeling requirements mandate that all pharmaceutical products display clear and accurate information, including the product name, active ingredients, dosage instructions, and expiration date, in accordance with SAHPRA guidelines.

Pharmacovigilance is a critical component of South Africa's pharmaceutical regulatory framework. Importers are required to have systems in place for monitoring and reporting adverse drug reactions to SAHPRA. Additionally, Good Manufacturing Practice (GMP) inspections are mandatory for foreign suppliers, including those in India, to ensure compliance with South African standards. The customs clearance process for pharmaceuticals can vary, but it typically takes several days to a few weeks, depending on factors such as the completeness of documentation, the efficiency of the inspection process, and the volume of goods being processed.